Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-03-19

FDA Approved: TRAVOPROST OPHTHALMIC — Original Application (Micro Labs Limited)

View source ↗

Summary

The FDA approved Micro Labs Limited's travoprost ophthalmic solution as an original application for reducing elevated intraocular pressure in patients with open…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TRAVOPROST OPHTHALMIC SOLUTION (Travoprost)

Snippet

ORIG AP for TRAVOPROST OPHTHALMIC (TRAVOPROST OPHTHALMIC SOLUTION)